Baillie Gifford & CO Bio N Tech Se Transaction History

Baillie Gifford & CO

$131 Billion
Q3 2024

A detailed history of Baillie Gifford & CO transactions in Bio N Tech Se stock. As of the latest transaction made, Baillie Gifford & CO holds 8,308,071 shares of BNTX stock, worth $939 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares

8,308,071

Previous 8,276,298 0.38%

Holding current value

$939 Million

Previous $665 Million 48.36%

% of portfolio

0.75%

Previous 0.53%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$78.36 - $124.66 $2.49 Million - $3.96 Million	31,773 Added 0.38%	8,308,071 $987 Million
Q2 2024 Jul 25, 2024	SELL	$80.36 - $102.87 $6.64 Million - $8.5 Million	-82,641 Reduced 0.99%	8,276,298 $665 Million
Q1 2024 May 01, 2024	SELL	$88.96 - $112.35 $29.4 Million - $37.1 Million	-330,243 Reduced 3.8%	8,358,939 $771 Million
Q4 2023 Jan 26, 2024	BUY	$90.91 - $112.75 $7.85 Million - $9.74 Million	86,343 Added 1.0%	8,689,182 $917 Million
Q3 2023 Nov 13, 2023	BUY	$98.5 - $125.08 $114 Million - $144 Million	1,152,541 Added 15.47%	8,602,839 $935 Million
Q2 2023 Jul 28, 2023	SELL	$102.58 - $129.66 $9.3 Million - $11.7 Million	-90,614 Reduced 1.2%	7,450,298 $804 Million
Q1 2023 May 03, 2023	SELL	$122.57 - $153.67 $21.7 Million - $27.2 Million	-177,211 Reduced 2.3%	7,540,912 $939 Million
Q4 2022 Jan 24, 2023	BUY	$118.43 - $186.05 $56 Million - $88 Million	473,051 Added 6.53%	7,718,123 $1.16 Billion
Q3 2022 Oct 27, 2022	SELL	$127.65 - $183.11 $2.29 Million - $3.28 Million	-17,908 Reduced 0.25%	7,245,072 $977 Million
Q2 2022 Aug 08, 2022	BUY	$123.25 - $186.24 $63.9 Million - $96.5 Million	518,283 Added 7.68%	7,262,980 $1.08 Billion
Q1 2022 May 05, 2022	BUY	$126.25 - $231.85 $26.8 Million - $49.2 Million	212,261 Added 3.25%	6,744,697 $1.15 Billion
Q4 2021 Jan 20, 2022	BUY	$216.64 - $362.52 $40.5 Million - $67.8 Million	187,123 Added 2.95%	6,532,436 $1.68 Billion
Q3 2021 Oct 19, 2021	SELL	$205.93 - $447.23 $17.4 Million - $37.8 Million	-84,436 Reduced 1.31%	6,345,313 $1.73 Billion
Q2 2021 Aug 02, 2021	SELL	$113.32 - $241.49 $34.9 Million - $74.4 Million	-308,263 Reduced 4.57%	6,429,749 $1.44 Billion
Q1 2021 May 06, 2021	BUY	$85.73 - $119.5 $578 Million - $805 Million	6,738,012 New	6,738,012 $736 Million

Others Institutions Holding BNTX

# of Institutions

357

Shares Held

38.3M

Call Options Held

2.45M

Put Options Held

2.29M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.4B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Account

Baillie Gifford & CO Bio N Tech Se Transaction History